Myeloproliferative Neoplasms: Fatigue, depression & hemoglobi
Open Access
- 2 July 2019
- journal article
- Published by Peertechz Publications Private Limited in Archives of Hematology Case Reports and Reviews
- Vol. 4 (1), 014-019
- https://doi.org/10.17352/ahcrr.000019
Abstract
To evaluate existing relationships and differences in fatigue, depression, and hemoglobin value in individuals with Myeloproliferative Neoplasms.Keywords
This publication has 32 references indexed in Scilit:
- Prevalence and Predictors of the Short-Term Trajectory of Anxiety and Depression in the First Year After a Cancer Diagnosis: A Population-Based Longitudinal StudyJournal of Clinical Oncology, 2013
- Diagnostic and statistical manual of mental disorders 5: A quick glanceIndian Journal of Psychiatry, 2013
- Cortisol and inflammatory processes in ovarian cancer patients following primary treatment: Relationships with depression, fatigue, and disabilityBrain, Behavior, and Immunity, 2012
- Inflammation and cancer-related fatigue: Mechanisms, contributing factors, and treatment implicationsBrain, Behavior, and Immunity, 2012
- Cultural beliefs and values in cancer patientsAnnals of Oncology, 2012
- Transformation of a Chronic Myeloproliferative Neoplasm to Acute Myelogenous Leukemia: Does Anything Work?Current Hematologic Malignancy Reports, 2011
- Association between quality of life and clinical parameters in patients with myeloproliferative neoplasmsLeukemia & Lymphoma, 2011
- Treatment-Related Risk Factors for Transformation to Acute Myeloid Leukemia and Myelodysplastic Syndromes in Myeloproliferative NeoplasmsJournal of Clinical Oncology, 2011
- Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studiesThe Lancet Oncology, 2011
- The Myelofibrosis Symptom Assessment Form (MFSAF): An evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosisLeukemia Research, 2009